RecruitingNot ApplicableNCT06858449

Resistance Training and Post Workout Protein to Improve Body Composition During Neoadjuvant Chemotherapy for Breast Cancer

NeoChemoPRT: A Randomized Study of Resistance Training and Post-Workout Protein to Improve Body Composition During Neoadjuvant Chemotherapy for Breast Cancer


Sponsor

Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

Enrollment

30 participants

Start Date

Jan 2, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

In this study, the investigators hypothesize that a high dose of post-workout protein nutrition regimen focused on food quality and an observed exercise regimen utilizing high-load resistance training initiated during or after cancer treatment will improve body composition and functional capacity.


Eligibility

Sex: FEMALEMin Age: 20 YearsMax Age: 89 Years

Inclusion Criteria4

  • Age 20-89 years
  • Women with a biopsy proven diagnosis of invasive carcinoma of the breast.
  • Women must undergo neoadjuvant chemotherapy for breast cancer treatment prior to surgery
  • Must be able to read and understand English and consent for themselves.

Exclusion Criteria7

  • Inability to get up and down off the ground or squat body weight
  • Inability to safely engage in group exercise sessions as deemed by study PI
  • Severe arthritic, joint, cardiovascular, musculoskeletal, or any other condition deemed by PI to be unsafe to engage in resistance training
  • Lactose intolerance
  • Cow's milk or whey protein allergy
  • Pregnant women
  • Males

Interventions

DIETARY_SUPPLEMENTWhey protein (20 grams)

20 grams of whey protein

DIETARY_SUPPLEMENTWhey protein (60 grams)

60 grams of whey protein.


Locations(1)

Allegheny General Hospital

Pittsburgh, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06858449


Related Trials